Consumer Study for the Evaluation of the Usability and Efficacy of One Medical Device in Venous Return
1 other identifier
interventional
52
1 country
1
Brief Summary
The primary goal of this study is to assess in vivo the efficacy of the insoles in improving venous return in subjects affected by this problem after 14 days of medical device use, by self-assessment, filling-in questions regarding Quality of Life, in comparison to the baseline. The secondary goals of this study are (1) to assess in vivo the perception of subjects about the rapid relief felt after 7 days of using the same medical device, by self-assessment, filling-in three subjective evaluation questions, and (2) to assess in vivo the usability of the subjects regarding the same medical device after 14 days of its use, by self-assessment, filling-in subjective evaluation questions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 10, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2023
CompletedFirst Submitted
Initial submission to the registry
November 22, 2023
CompletedFirst Posted
Study publicly available on registry
December 1, 2023
CompletedDecember 1, 2023
November 1, 2023
2 months
November 22, 2023
November 22, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Quality of Life
Quality of Life evaluation before (t0) and after 14 days (t14) of using the medical device Therapeutic insoles LIGHT LEGS, to assess the quality-of-life improvement subjects;
Day 0 and Day 14
Secondary Outcomes (2)
Rapid relief
Day 7
Usability evaluation
Day 14
Study Arms (1)
One medical device as investigational device
EXPERIMENTALInterventions
Device : Insoles At Day 0, the patient received the insoles and adapted them to his shoes. The patient filled the quality-of-life's questionnaire at Day 0 and the same at Day14. The patient filled the rapid relief's questionnaire at Day7 and a usability's questionnaire at Day14.
Eligibility Criteria
You may qualify if:
- Gender: Female/Male;
- Age: with 18 years old and older;
- Having signed an Informed Consent Form (ICF);
- Willingness, ability and likeliness to comply with all the study procedures and restrictions;
- Ability to give informed consent;
- Available during the entire study period;
- Understanding Portuguese language: Portuguese-speaking subjects capable of reading the documents;
- Affected by a symptomatic venous return problem;
You may not qualify if:
- Known allergy or known history of hypersensitivity to the components of the investigational device and related compounds;
- Currently participating in another clinical study that may interfere with the study;
- Diagnosed skin diseases and/or cutaneous alterations on the test region (feet) that may impair the study (for example tattoos, marks, burns, scars, etc.);
- Diagnosed diseases that may impair the study (including but not limited to: Diabetes, Arteritis, Phlebitis, etc);
- Under pharmacological treatments on the 30 days previous to the beginning of the study and during the entire period of the study that may impair it (including but not limited to: inflammatory drugs, any drug that might cover the signs and symptoms, drugs with arterial or venous indications, etc.);
- Having applied any type of topical product (pharmaceutical, cosmetic or other) with similar effect of the medical device under study, on the test region (feet) during the study, besides the investigational device;
- Having a stage of CVD C3 on the CEAP classification;
- Having had a traumatic or neurological history in the last 6 months;
- Wearing an orthopaedic insole made by a health professional;
- Having a significant and disabling lower limb pain;
- Having a significant and disabling back pain;
- Having a contraindication to wearing insoles;
- Pregnancy or intention to conceive during the study;
- Breast-feeding
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Inovapotek
Porto, 4200-135, Portugal
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marta de Oliveira Ferreira
INOVAPOTEK
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 22, 2023
First Posted
December 1, 2023
Study Start
May 10, 2023
Primary Completion
June 30, 2023
Study Completion
June 30, 2023
Last Updated
December 1, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share